Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice
Chloe Sligar(University of Wollongong), Debbie Watson(University of Wollongong), Ronald Sluyter(University of Wollongong), Ellie Reilly(University of Wollongong), Kara L. Vine(University of Wollongong), Stephen I. Alexander(University of South Australia), Katrina M. Bird(University of Wollongong), Peter Cuthbertson(Migration Institute of Australia), Amal Elhage(University of Wollongong)
Cited by 5
Related Papers
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269
Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
|Advanced Materials|2018|217
In vitro cytotoxicity evaluation of some substituted isatin derivatives
|Bioorganic & Medicinal Chemistry|2006|193